1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Danone
  6. News
  7. Summary
    BN   FR0000120644


Real-time Euronext Paris  -  11:35 2022-08-09 am EDT
53.57 EUR   -0.06%
08/05WPP Boosts Full-year Sales Outlook After Client Demand Drives Interim Earnings
08/02A2 Milk jumps before halt on FDA nod news, denies report
07/29DANONE : First Supplement to EMTN base prospectus
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Baby formula crunch in U.S. forces scramble to boost supplies

06/06/2022 | 01:24pm EDT
FILE PHOTO: Empty shelves show a shortage of baby formula in San Antonio

(Reuters) - Abbott Laboratories said on Saturday it had reopened its baby formula production plant in Michigan, a crucial step that could help ease a nationwide shortage of baby formula in the coming weeks.

Top infant formula makers, including Reckitt Benckiser, Nestle and Danone SA, have been shipping supplies from overseas since the United States temporarily allowed foreign imports from other suppliers.

Here is a timeline on how the baby formula crisis unfolded and the measures taken so far to resolve it:

Feb. 17

Abbott recalls dozens of types of powdered baby formulas, including Similac, Alimentum and EleCare, made at its Sturgis, Michigan plant after four consumers complained about bacterial infections in infants who had consumed those products; Recalled products had an expiry date of April 1, 2022 or later.

Feb. 21

China's custom officials warn consumers against buying and consuming certain of Abbott's infant and baby products.

Feb. 28

Abbott expands recall to include some Similac PM 60/40 products based on a fifth complaint of a bacterial infection.

March 4

House Appropriations Committee Chairwoman Rosa DeLauro asks for an investigation https://delauro.house.gov/media-center/press-releases/chair-delauro-requests-investigation-fda-handling-abbott-powdered-infant into the FDA's handling of the Abbott recall.

March 22

FDA probe of Abbott's Michigan facility finds a harmful bacteria called Cronobacter sakazakii on the surface of some areas near infant formula production, and reveals Abbott did not have a control system in place to prevent microbe contamination.

April 20

Abbott, calling the recall a "short-term hindrance", cuts its full-year sales growth forecast but maintains profit estimate.

April 28

House Appropriations Committee Chair Rosa DeLauro in a testimony submits a report acquired from a whistleblower, who had worked at the Abbott facility and had filed a complaint with the FDA in September 2021.

April 29

Abbott says it will release some nutrition products made at its Michigan plant on a case-by-case basis.

May 10

Major U.S. retailers including Target Corp, CVS Health Corp, Walgreens Boots Alliance and Kroger Co place purchase limits on infant formula products.

Abbott says it has been prioritizing production of formula at other plants, and shipping formula from its Ireland facility.

May 12

President Joe Biden meets with executives from baby formula manufacturers and retailers including Target, Walmart and Nestle's Gerber to address the shortage.

May 13

Store-brand baby formula maker Perrigo Co says shortages and heightened demand may last for the rest of the year.

U.S. Centers for Disease Control and Prevention (CDC) closes its investigation on Abbott, while Abbott says it has air shipped millions of cans of baby formula powder into the United States from its facility in Ireland.

May 16

The FDA says the United States will allow imports of infant formula from foreign makers that do not usually sell their products in the country.

Abbott reaches an agreement with the FDA on the steps needed to resume production at its Michigan plant.

May 17

U.S. House Democrats unveils a bill to provide $28 million in emergency funds to the FDA to help it respond to the shortage and bolster supervision of the industry.

Nestle SA tells Reuters it was flying supplies to the United States from the Netherlands and Switzerland. Reckitt Benckiser, the second largest U.S. milk formula supplier, is boosting baby formula production by about 30%.

May 18

U.S. President Joe Biden invokes the Defense Production Act to help manufacturers obtain the ingredients needed to ramp up supply.

May 20

French baby formula maker Danone SA ramps up shipments of infant formula from Europe to the United States, according to U.S. customs data and shipping consultancy Ocean Audit.

May 24

Abbott says it plans to restart production at the facility on June 4.

The U.S. Federal Trade Commission launches an inquiry into the ongoing shortage and to examine past M&A deals in the formula market to understand their impact.

May 25

Danone says it has been doubling shipments of Neocate formula to the United States, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage.

Lawmakers grill FDA officials over what they called a lack of urgency in the agency's response to complaints about possible baby formula contamination at Abbott's Sturgis plant.

June 4

Abbott says it has reopened its baby formula production plant in Sturgis, Michigan.

(Reporting by Deborah Sophia and Leroy Leo in Bengaluru; Editing by Anil D'Silva, Sriraj Kalluvila and Shinjini Ganguli)

© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.66% 103.69 Delayed Quote.-1.12%
DANONE -0.06% 53.57 Real-time Quote.-1.81%
KROGER -0.47% 46.87 Delayed Quote.4.40%
NESTLÉ S.A. 0.05% 115.56 Delayed Quote.-9.37%
PERRIGO COMPANY PLC -2.37% 41.57 Delayed Quote.9.46%
RECKITT BENCKISER GROUP PLC 0.27% 6662 Delayed Quote.4.76%
S&P GSCI CLASS III MILK (USD) 2.75% 153.3789 Real-time Quote.-5.12%
TARGET CORPORATION -1.11% 165.12 Delayed Quote.-28.22%
WALGREENS BOOTS ALLIANCE, INC. -0.89% 39.13 Delayed Quote.-24.31%
WALMART INC. 0.99% 128.87 Delayed Quote.-12.52%
All news about DANONE
08/05WPP Boosts Full-year Sales Outlook After Client Demand Drives Interim Earnings
08/02A2 Milk jumps before halt on FDA nod news, denies report
07/29DANONE : First Supplement to EMTN base prospectus
07/29DANONE : Premier supplément au Prospectus de base du programme EMTN
07/29DANONE : Berenberg gives a Neutral rating
07/29DANONE : Gets a Sell rating from Goldman Sachs
07/28DANONE : Gets a Neutral rating from Credit Suisse
07/28Nestle profits as shoppers defy rising prices
07/28DANONE : UBS reiterates its Sell rating
07/28DANONE : Buy rating from JP Morgan
More news
Analyst Recommendations on DANONE
More recommendations
Sales 2022 26 849 M 27 462 M 27 462 M
Net income 2022 1 608 M 1 645 M 1 645 M
Net Debt 2022 10 597 M 10 839 M 10 839 M
P/E ratio 2022 20,2x
Yield 2022 3,70%
Capitalization 34 251 M 35 032 M 35 032 M
EV / Sales 2022 1,67x
EV / Sales 2023 1,57x
Nbr of Employees 98 105
Free-Float 90,0%
Duration : Period :
Danone Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANONE
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 53,57 €
Average target price 58,68 €
Spread / Average Target 9,54%
EPS Revisions
Managers and Directors
Antoine Bernard de Saint-Affrique Chief Executive Officer & Director
Juergen Esser Chief Financial, Technology & Data Officer
Gilles Schnepp Non-Executive Chairman
Isabelle Esser Chief Research, Innovation & Food Safety Officer
Vikram Agarwal Chief Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DANONE-1.81%35 023
NESTLÉ S.A.-9.37%334 280